Naoki Suzuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Naoki Suzuki has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Eskil Elmér
Department of Clinical Sciences, Mitochondrial Medicine, Lund University
1 shared publication - Hiroyuki Uchino
Department of Anesthesiology, Tokyo Medical University, Tokyo 1600023, Japan
1 shared publication - Masahiro Sugimoto
Institute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Yamagata, Japan
1 shared publication - Shoichiro Shibata
Department of Anesthesiology, Tokyo Medical University, Tokyo 1600023, Japan
1 shared publication
Latest Publications
- Open Access
- 9 September 2025
- Published by MDPI AG in Metabolites
- Vol. 15 (9) , 600
Time-Resolved Metabolomics Reveals Mitochondrial Protection in Septic Liver Injury
Background/Objectives: Sepsis is a life-threatening condition characterized by organ dysfunction due to a dysregulated host response to infection. Mitochondrial dysfunction is considered a key contributor to the pathogenesis of sepsis, but its molecular mechanisms remain unclear. Methods: In this study, we used a cecal ligation and puncture (CLP) model to induce sepsis in wild-type (WT) and cyclophilin D knockout (CypD KO) mice. Liver tissues were collected at 0, 6, and 18 h post-CLP and analyzed using liquid chromatography–tandem mass spectrometry (LC-MS/MS). Results: Metabolomic profiling revealed that lactate levels significantly increased in the WT mice but remained stable in the KO mice. While AMP levels were preserved in the KO mice, these mice had significantly higher glutathione disulfide (GSSG) and spermidine concentrations than the WT mice at 18 h (p < 0.05). The levels of malondialdehyde (MDA), a marker of oxidative stress, were also significantly lower in the KO mice at 18 h (p < 0.05). These findings suggest that CypD deficiency preserves mitochondrial function, enhances resistance to oxidative stress, and mitigates septic liver injury. Conclusions: Our results highlight the potential of targeting mitochondrial permeability transition as a therapeutic strategy for sepsis.
- 9 September 2025
- Published by MDPI AG in Metabolites
- Vol. 15 (9) , 600
Open AccessTime-Resolved Metabolomics Reveals Mitochondrial Protection in Septic Liver Injury
Background/Objectives: Sepsis is a life-threatening condition characterized by organ dysfunction due to a dysregulated host response to infection. Mitochondrial dysfunction is considered a key contributor to the pathogenesis of sepsis, but its molecular mechanisms remain unclear. Methods: In this study, we used a cecal ligation and puncture (CLP) model to induce sepsis in wild-type (WT) and cyclophilin D knockout (CypD KO) mice. Liver tissues were collected at 0, 6, and 18 h post-CLP and analyzed using liquid chromatography–tandem mass spectrometry (LC-MS/MS). Results: Metabolomic profiling revealed that lactate levels significantly increased in the WT mice but remained stable in the KO mice. While AMP levels were preserved in the KO mice, these mice had significantly higher glutathione disulfide (GSSG) and spermidine concentrations than the WT mice at 18 h (p < 0.05). The levels of malondialdehyde (MDA), a marker of oxidative stress, were also significantly lower in the KO mice at 18 h (p < 0.05). These findings suggest that CypD deficiency preserves mitochondrial function, enhances resistance to oxidative stress, and mitigates septic liver injury. Conclusions: Our results highlight the potential of targeting mitochondrial permeability transition as a therapeutic strategy for sepsis.